Skip to main content
. 2017 Dec 28;4(2):11–17. doi: 10.14338/IJPT-17-00017

Table 1.

Patient characteristics.

Patient
Age (y)
Sex
Stage
Primary dose (Gy)
Elective intermediate dose (Gy)
Elective low dose (Gy)
No. of fractions
PTV V95 IMPT (%)
PTV V95 VMAT (%)
1 76 M T2N0 50.4 45 28 99.96 99.14
2 48 F T3N3 54 50.4 45 30 95.26 91.95
3 84 F T3N2 54 50.4 45 30 97.97 98.59
4 62 M T2N0 50.4 42 28 99.58 99.01
5 50 F T3N0 54 45 30 100 100
6 57 M T4N1 54 45 30 99.45 98.24
7 56 M T3N2 54 50.4 45 30 99.6 97.29
8 60 F T3N1 54 50.4 45 30 100 99.24
9 70 F T2N0 50.4 42 28 100 99.53

Abbreviations: PTV, planning target volume; IMPT, intensity-modulated proton therapy; VMAT, volumetric arc therapy; M, male; F, female.